Mily Elizabeth
SEC CIK 1808438 · EDGAR
Most active insiders at SOLV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wendell Amy McBride | Dir | $100.3K | — |
| 2 | Wilcox Mary T | CAO | — | — |
| 3 | Harrington Paul S | Chief Supply Chain Off | — | — |
| 4 | Landucci Amy | CIO | — | — |
| 5 | Edwards Shirley Ann | Dir | — | — |
| 6 | Gomez Tammy L | CHRO | — | — |
| 7 | Kirberger Marcela A. | Chief Legal Affairs Off | — | — |
| 8 | Mily Elizabeth | Dir | — | — |
| 9 | McMillan Wayde D. | CFO | — | — |
| 10 | Wilson Darryl L. | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-01 16:30 | 2026-04-30 | SOLV | Solventum | Mily Elizabeth | Dir | M - OptEx | $0.00 | +3,403 | 9,009 | +61% | $0 |
| D | 2026-03-30 | 2026-03-27 | SOLV | Solventum | Mily Elizabeth | Dir | M - OptEx | $0.00 | +1,980 | 5,606 | +55% | $0 |
| D | 2025-05-15 | 2025-05-13 | SOLV | Solventum | Mily Elizabeth | Dir | M - OptEx | $0.00 | +3,564 | 3,626 | +5,748% | $0 |
| D | 2023-04-04 | 2023-04-01 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +1,190 | 35.2K | +3% | $0 |
| DM | 2023-04-04 | 2023-04-01 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $69.31 | -3,198 | 33.2K | -9% | -$221.7K |
| DM | 2023-04-04 | 2023-04-01 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +6,346 | 35.9K | +21% | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +29.6K | 17.7K | New | $0 |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $65.71 | -14.0K | 14.0K | -50% | -$922.6K |
| DM | 2023-03-14 | 2023-03-10 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +3,458 | 16.0K | +28% | $0 |
| DM | 2022-04-04 | 2022-04-01 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +6,347 | 12.5K | +103% | $0 |
| D | 2022-04-04 | 2022-04-01 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +1,508 | 12.0K | +14% | $0 |
| DM | 2022-04-04 | 2022-04-01 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $73.82 | -3,333 | 9,796 | -25% | -$246.0K |
| D | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +4,005 | 8,246 | +94% | $0 |
| D | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $68.42 | -1,875 | 6,820 | -22% | -$128.3K |
| D | 2022-03-14 | 2022-03-10 | BMY | Bristol Myers Squibb | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +449 | 8,695 | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations